Hamps Bio Ltd Stock Price Today (NSE: HAMPS)
Fundamental Score
Hamps Bio Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Hamps Bio Ltd share price today is ₹16.55, up +0.00% on NSE/BSE as of 30 March 2026. Hamps Bio Ltd (HAMPS) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹21.34 (Cr). The 52-week high for HAMPS share price is ₹N/A and the 52-week low is ₹13.36. The company has a Return on Equity (ROE) of 4.94% and a debt-to-equity ratio of 0.44.
Hamps Bio Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Hamps Bio Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Hamps Bio Share Price Analysis: A ROCE-Focused Perspective
The Other Agricultural Products sector faces a unique challenge: balancing innovation in biotechnology with the inherent uncertainties of agricultural yields. This analysis focuses on Hamps Bio share price and its Return on Capital Employed (ROCE) to gauge its financial health. Currently trading at ₹16.53, Hamps Bio presents an interesting case given its ROCE of 6.68% and lack of a Price-to-Earnings (PE) ratio.
ROCE is a critical metric for evaluating a company's efficiency in generating profits from its capital investments. A ROCE of 6.68% suggests that for every ₹100 invested in the business, Hamps Bio generates ₹6.68 in profit. This raises questions about the company's capital allocation strategy and its ability to compete effectively within its sector. Comparing Hamps Bio Ltd to its peers is crucial. For example, comparing management quality to
Kaveri Seed Company Limited can provide valuable insights into Hamps Bio's operational efficiency and strategic direction. A more efficient management team may lead to better capital allocation and higher ROCE in the future.The 6.68% ROCE directly impacts Hamps Bio's competitive moat. A lower ROCE compared to its peers suggests a weaker moat, indicating potentially less pricing power, lower barriers to entry for competitors, and reduced ability to reinvest profits for future growth. Companies with strong moats typically exhibit higher ROCE figures, reflecting their ability to generate sustainable returns on capital. A higher ROCE, achievable through cost optimization, product innovation, or market differentiation, strengthens the moat and makes the company more resilient to competitive pressures. Conversely, a ROCE below the industry average suggests a need for improvement in operational efficiency and strategic positioning.
The absence of a PE ratio could indicate a lack of consistent profitability or negative earnings. This, combined with the 6.68% ROCE, warrants a deeper investigation into the company's financial statements to understand the underlying drivers of its performance. This analysis is part of a larger 80-parameter fundamental audit verified by Sweta Mishra, focusing on key financial metrics and comparative analysis within the Other Agricultural Products sector. This analysis aims to provide an observational perspective on Hamps Bio's financial standing.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Hamps Bio Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of HAMPS across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Balanced Promoter Holding (71.99%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (4.94%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.68%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-174.07%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Interest Coverage (0.12x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Hamps Bio Ltd Financial Statements
Comprehensive financial data for Hamps Bio Ltd including income statement, balance sheet and cash flow
About HAMPS (Hamps Bio Ltd)
Hamps Bio Ltd is a pioneering force in the realm of agricultural innovation, specializing in the development and distribution of cutting-edge bio-products that enhance crop yields ...and promote sustainable farming practices. Unlike traditional agricultural input suppliers, HAMPS focuses on harnessing the power of naturally derived compounds and beneficial microorganisms to create solutions that improve soil health, enhance plant resilience, and optimize nutrient uptake. Their diverse product portfolio includes bio-fertilizers, bio-pesticides, and soil conditioners meticulously formulated to meet the specific needs of various crops and geographical regions. Committed to environmental stewardship, HAMPS champions eco-friendly alternatives that minimize reliance on synthetic chemicals and contribute to a healthier planet. Beyond their core product offerings, HAMPS Bio Ltd is deeply invested in research and development, constantly exploring new frontiers in agricultural biotechnology. Their team of scientists and agronomists work tirelessly to identify novel bio-active ingredients and develop innovative formulations that address emerging challenges in the agricultural landscape. Through strategic partnerships with research institutions and agricultural universities, HAMPS fosters a collaborative ecosystem that accelerates the translation of scientific discoveries into practical solutions for farmers. This dedication to innovation ensures that HAMPS remains at the forefront of the bio-agricultural revolution, empowering farmers with the tools they need to achieve sustainable and profitable yields. HAMPS Bio Ltd distinguishes itself through its unwavering commitment to quality and customer satisfaction. All products undergo rigorous testing and quality control measures to ensure efficacy, safety, and consistency. The company provides comprehensive technical support and training to farmers, empowering them to effectively utilize HAMPS' bio-products and optimize their farming practices. Furthermore, HAMPS is committed to building long-term relationships with its customers, fostering trust and collaboration to achieve shared success. With a strong focus on sustainability, innovation, and customer-centricity, HAMPS Bio Ltd is poised to play a pivotal role in shaping the future of agriculture.
Company Details
Key Leadership
Latest News
HAMPS Share Price: Frequently Asked Questions
What is the current share price of Hamps Bio Ltd (HAMPS)?
As of 30 Mar 2026, 12:06 pm IST, Hamps Bio Ltd share price is ₹16.55. The HAMPS stock has a market capitalisation of ₹21.34 (Cr) on NSE/BSE.
Is HAMPS share price Overvalued or Undervalued?
HAMPS share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 21.07x. Based on this relative valuation, the Hamps Bio Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of HAMPS share price?
The 52-week high of HAMPS share price is ₹N/A and the 52-week low is ₹13.36. These values are updated daily from NSE/BSE price data.
What factors affect the Hamps Bio Ltd share price?
Key factors influencing HAMPS share price include quarterly earnings growth (Sales Growth: 12.71%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Hamps Bio Ltd a good stock for long-term investment?
Hamps Bio Ltd shows a 5-year Profit Growth of N/A% and an ROE of 4.94%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.44 before investing in HAMPS shares.
How does Hamps Bio Ltd compare with its industry peers?
Hamps Bio Ltd competes with major peers in the Other Agricultural Products. Investors should compare HAMPS share price P/E of 0.00x and ROE of 4.94% against the industry averages to determine competitive standing.
What is the P/E ratio of HAMPS and what does it mean?
HAMPS share price has a P/E ratio of N/Ax compared to the industry average of 21.07x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is HAMPS performing according to Bull Run's analysis?
HAMPS has a Bull Run fundamental score of 16.4/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does HAMPS belong to?
HAMPS operates in the Other Agricultural Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Hamps Bio Ltd share price.
What is Return on Equity (ROE) and why is it important for HAMPS?
HAMPS has an ROE of 4.94%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Hamps Bio Ltd generates profits from shareholders capital.
How is HAMPS debt-to-equity ratio and what does it indicate?
HAMPS has a debt-to-equity ratio of 0.44, which indicates moderate leverage that should be monitored.
What is HAMPS dividend yield and is it a good dividend stock?
HAMPS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Hamps Bio Ltd shares.
How has HAMPS share price grown over the past 5 years?
HAMPS has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in HAMPS and why does it matter?
Promoters hold 71.99% of HAMPS shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Hamps Bio Ltd.
What is HAMPS market capitalisation category?
HAMPS has a market capitalisation of ₹21 crores, placing it in the Small-cap category.
How volatile is HAMPS stock?
HAMPS has a beta of N/A. A beta > 1 suggests the Hamps Bio Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is HAMPS operating profit margin trend?
HAMPS has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is HAMPS quarterly performance?
Recent quarterly performance shows Hamps Bio Ltd YoY Sales Growth of 12.71% and YoY Profit Growth of -174.07%.
What is the institutional holding pattern in HAMPS?
HAMPS has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Hamps Bio Ltd stock.